ALLE
44
5
RIG
58
3
ROK
42
4
MDT
59
2
JCI
45
4
XOM
42
2
ETN
69
2
CNX
75
6
BMY
43
2
AN
47
3
MPC
31
5
ROST
57
3
CMI
59
14
PEP
47
2
THC
67
2
WY
53
2
GS
63
11
D
41
4
HRB
56
2
AEE
55
5
ALLE
44
5
RIG
58
3
ROK
42
4
MDT
59
2
JCI
45
4
XOM
42
2
ETN
69
2
CNX
75
6
BMY
43
2
AN
47
3
MPC
31
5
ROST
57
3
CMI
59
14
PEP
47
2
THC
67
2
WY
53
2
GS
63
11
D
41
4
HRB
56
2
AEE
55
5
Financhill
Back

Genmab AS Vs. Evaxion Biotech AS Industry Stock Comparison

Sell
33

GNMSF
Genmab AS

Last Price:
220.28
Seasonality Move:
-0.03%
Sell
6

EVAX
Evaxion Biotech AS

Last Price:
2.61
Seasonality Move:
-39.53%
Sell
33
Genmab AS (GNMSF) is a Sell

Is Genmab AS a Buy, Sell or Hold?

  • The current Genmab AS [GNMSF] share price is $220.28. The Score for GNMSF is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • GNMSF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
6
Evaxion Biotech AS (EVAX) is a Sell

Is Evaxion Biotech AS a Buy, Sell or Hold?

  • The current Evaxion Biotech AS [EVAX] share price is $2.61. The Score for EVAX is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • EVAX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

GNMSF Stock Price Chart

What is Genmab AS's stock price today?

  • The Genmab AS share price today is $220.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GNMSF is experiencing selling pressure, which indicates risk of future bearish movement.

EVAX Stock Price Chart

What is Evaxion Biotech AS's stock price today?

  • The Evaxion Biotech AS share price today is $2.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVAX is experiencing slight buying pressure.

GNMSF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.23 Sell
Relative Strength Index (14 RSI): 41.2 Sell
Chaikin Money Flow: -949 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (222.46 - 235.62) Sell
Bollinger Bands (100): (236.16 - 272.06) Sell

EVAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 43.16 Sell
Chaikin Money Flow: 91 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.6 - 2.88) Sell
Bollinger Bands (100): (2.68 - 3.18) Sell

GNMSF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 223.15 Sell
20-day SMA: 227.14 Sell
50-day SMA: 245.41 Sell
200-day SMA: 270.4 Sell
8-day EMA: 223.07 Sell
20-day EMA: 227.93 Sell
50-day EMA: 240.13 Sell
200-day EMA: 271.79 Sell

EVAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.73 Sell
20-day SMA: 2.68 Sell
50-day SMA: 2.93 Sell
200-day SMA: 3.43 Sell
8-day EMA: 2.68 Sell
20-day EMA: 2.73 Sell
50-day EMA: 2.85 Sell
200-day EMA: 4.18 Sell

Genmab AS Earnings Growth & GNMSF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Evaxion Biotech AS Earnings Growth & EVAX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.58 per share, and an increase next year of $0.04 per share.

Genmab AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Evaxion Biotech AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):